Immediate Impact
64 standout
Citing Papers
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Works of Manuel Figueroa being referenced
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Manuel Figueroa | 510 | 612 | 1002 | 54 | 1.9k | |
| Shigeko Inokuma | 339 | 550 | 1245 | 76 | 2.3k | |
| Vicente Rodríguez‐Valverde | 413 | 1128 | 1981 | 66 | 3.1k | |
| Peter T. Chapman | 746 | 324 | 1227 | 82 | 3.1k | |
| César Hernández‐García | 206 | 743 | 1152 | 39 | 1.8k | |
| Évangéline Pillebout | 382 | 944 | 492 | 61 | 2.4k | |
| Allan L. Metzger | 606 | 355 | 1402 | 49 | 2.9k | |
| Michael Seitz | 144 | 639 | 984 | 62 | 2.4k | |
| Andrew Exley | 349 | 1165 | 585 | 44 | 2.3k | |
| Carine Salliot | 283 | 136 | 1446 | 62 | 2.4k | |
| J. Dixey | 227 | 569 | 1739 | 48 | 2.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...